Patents Assigned to ILTOO PHARMA
  • Pharmaceutical compositions of IL-2
    Patent number: 11883531
    Abstract: The invention relates to a liquid pharmaceutical composition of Il-2 and its use in the treatment of auto-immune and inflammatory disorders. Methods for preparing said composition and delivery devices filled with said composition are also described.
    Type: Grant
    Filed: July 13, 2020
    Date of Patent: January 30, 2024
    Assignee: ILTOO PHARMA
    Inventors: Jérémie Mariau, Michel Thiry
  • Use of interleukin 2 for treating Sjögren's syndrome
    Patent number: 11534479
    Abstract: The invention relates to the use of interleukin-2 in treating Sjögren's syndrome in a subject, wherein IL-2 is to be administered at a low dose of less than about 3.5 MIU/day.
    Type: Grant
    Filed: February 18, 2019
    Date of Patent: December 27, 2022
    Assignees: ILTOO PHARMA, ASSISTANCE PUBLIQUE—HÖPITAUX DE PARIS, SORBONNE UNIVERSITÉ
    Inventors: David Klatzmann, Roberta Lorenzon, Michèle Rosenzwajg, Patrice Cacoub, Arsene Mekinian
  • PHARMACEUTICAL COMPOSITIONS OF IL-2
    Publication number: 20210128465
    Abstract: The invention relates to a liquid pharmaceutical composition of Il-2 and its use in the treatment of auto-immune and inflammatory disorders. Methods for preparing said composition and delivery devices filled with said composition are also described.
    Type: Application
    Filed: July 13, 2020
    Publication date: May 6, 2021
    Applicant: ILTOO PHARMA
    Inventors: Jérémie MARIAU, Michel THIRY
  • USE OF INTERLEUKIN 2 FOR TREATING SJÖGREN'S SYNDROME
    Publication number: 20210121532
    Abstract: The invention relates to the use of interleukin-2 in treating Sjögren's syndrome in a subject, wherein IL-2 is to be administered at a low dose of less than about 3.5 MIU/day.
    Type: Application
    Filed: February 18, 2019
    Publication date: April 29, 2021
    Applicants: ILTOO PHARMA, ASSISTANCE PUBLIQUE - HÖPITAUX DE PARIS, SORBONNE UNIVERSITÉ
    Inventors: David KLATZMANN, Roberta LORENZON, Michèle ROSENZWAJG, Patrice CACOUB, Arsene MEKINIAN
  • Pharmaceutical compositions of IL-2
    Patent number: 10722460
    Abstract: The invention relates to a liquid pharmaceutical composition of Il-2 and its use in the treatment of auto-immune and inflammatory disorders. Methods for preparing said composition and delivery devices filled with said composition are also described.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: July 28, 2020
    Assignee: ILTOO Pharma
    Inventors: Jérémie Mariau, Michel Thiry
  • USE OF INTERLEUKIN 2 FOR TREATING SPONDYLOARTHRITIS
    Publication number: 20190060407
    Abstract: The invention relates to the use of interleukin-2 in treating spondyloarthritis in a human subject, wherein IL-2 is to be administered at a dose of about I to about 2 MIU/day, wherein the treatment comprises at least a first course wherein interleukin-2 is administered once per day during at least 3 consecutive days, followed by a maintenance treatment after 1 to 4 weeks.
    Type: Application
    Filed: September 9, 2016
    Publication date: February 28, 2019
    Applicants: Assistance Publique - Hôpitaux De Paris, ILTOO PHARMA, SORBONNE UNIVERSITE
    Inventors: David Klatzmann, Francis Berenbaum, Jérémie Sellam, Bruno Fautrel, Roberta Lorenzon, Patrice Cacoub
  • PHARMACEUTICAL COMPOSITIONS OF IL-2
    Publication number: 20180303754
    Abstract: The invention relates to a liquid pharmaceutical composition of I1-2 and its use in the treatment of auto-immune and inflammatory disorders. Methods for preparing said composition and delivery devices filled with said composition are also described.
    Type: Application
    Filed: October 20, 2016
    Publication date: October 25, 2018
    Applicant: ILTOO PHARMA
    Inventors: Jérémie MARIAU, Michel THIRY